4.7 Review

Modeling Barrier Tissues In Vitro: Methods, Achievements, and Challenges

期刊

EBIOMEDICINE
卷 5, 期 -, 页码 30-39

出版社

ELSEVIER
DOI: 10.1016/j.ebiom.2016.02.023

关键词

Microfluidic technologies; Barrier tissues; In vitro modeling; Organ-on-a-chip; Drug discovery; Microphysiological systems

资金

  1. Div Of Civil, Mechanical, & Manufact Inn
  2. Directorate For Engineering [1436173] Funding Source: National Science Foundation
  3. NCATS NIH HHS [KL2 TR001080, UL1 TR001082, UH2TR000156-01, KL2 TR000156] Funding Source: Medline
  4. NIEHS NIH HHS [NIH 1R15ES022828, R15 ES022828] Funding Source: Medline

向作者/读者索取更多资源

Organ-on-a-chip devices have gained attention in the field of in vitro modeling due to their superior ability in recapitulating tissue environments compared to traditional multiwell methods. These constructed growth environments support tissue differentiation and mimic tissue-tissue, tissue-liquid, and tissue-air interfaces in a variety of conditions. By closely simulating the in vivo biochemical and biomechanical environment, it is possible to study human physiology in an organ-specific context and create more accurate models of healthy and diseased tissues, allowing for observations in disease progression and treatment. These chip devices have the ability to help direct, and perhaps in the distant future even replace animal-based drug efficacy and toxicity studies, which have questionable relevance to human physiology. Here, we review recent developments in the in vitro modeling of barrier tissue interfaces with a focus on the use of novel and complex microfluidic device platforms. (C) 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据